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Introduction
Ginseng, one of the most famous medicinal herbs, has been used widely in Asia, Europe, and North America. The major pharmacologically active components of ginseng are ginsenosides, a diverse group of steroidal saponins that target multitudinous tissues, producing an array of pharmacological responses (Lee et al., 2005a; Park et al., 2004; Kim et al., 2003) . The most abundant ginsenosides can be subdivided into two classes based on the aglycones: 20(S)-protopanaxadiol (PPD) type and 20(S)-protopanaxatriol (PPT) type Tanaka et al., 1966) .
PPD is one of the aglycones of the ginsenosides. This compound has a wide range of pharmacologic activities, including those that are anti-estrogenic (Yu et al., 2007; Leung et al., 2009), anti-inflammatory (Lee et al., 2005b; Lee et al., 2006) , antitumor (Zhang et al., 2008; Popovich et al., 2004; Liu et al., 2007; Usami et al., 2008) , vasodilator (Chang et al., 1994) , and anti-nociceptive (Shin et al., 1997) . It has been found to have inhibitory effects on CYP3A activity (Liu et al., 2004; Liu et al., 2006) . Hui et al. (2006) have reported that PPD markedly increases the levels of norepinephrine and 5-hydroxytryptamine (5-HT) in the brain of rats with symptoms of depression, and significantly enhances the tremor effect of 5-HT (Hui et al., 2006) . Currently, PPD has progressed to early clinical antidepressant trials.
Our previous experiment shows that its oral bioavailability is low (rats: 31%, 25 mg/kg; dogs: 9.6%, 8 mg/kg) due to its extensive metabolism in the gastrointestinal tract. Kasai et al. have found that incubation of PPD with microsomes from rat livers has led to the formation of its 20,24-oxides as major metabolites (Kasai et al., 2000) . By comparison of FAB-MS, EI-MS and retention time of HPLC with those of authentic samples derived from PPD by oxidation with 3-chloroperoxybenzoic acid, the formation of (20S,24S)-epoxydammarane-3,12,25-triol (2) was confirmed. Due to overlaps This article has not been copyedited and formatted. The final version may differ from this version. DMD Fast Forward. Published on December 7, 2010 as DOI: 10.1124 at ASPET Journals on November 6, 2017 dmd.aspetjournals.org
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6 with other minor peaks in the HPLC, the formation of (20S,24R)- epoxydammarane-3,12,25-triol (3) was ambiguous. Remarkably, there have been no reports of its metabolism in humans. In this study, its fate in HLMs and human hepatocytes were examined by means of LC/MS n . The objective of this study was to gain understanding about the whole metabolic route of PPD in humans including the biotransformation to the 24,25-epoxide metabolites.
This article has not been copyedited and formatted. The final version may differ from this version. for column chromatography, and pre-coated silica gel GF254 plates (Qingdao Marine Chemical Plant, Qingdao, China) were used for thin-layer chromatography (TLC). 3-Chloroperoxybenzoic acid (m-CPBA) was purchased from Alfa Aesar China (Tianjin) Co., Ltd.
Microsomal Incubations of PPD and the Isolated Metabolites. All incubations were performed at 37°C in a water bath shaker. Stock solution of PPD was prepared in MeOH. The final concentration of MeOH in the incubation was 0.1% (v/v). The pooled human liver microsomes (HLMs) were carefully thawed on ice prior to the experiment. HLM proteins (1.0 mg/ml) were added to a solution of PPD (50 µM) in 100 mM potassium phosphate buffer (pH 7.4). The total incubation volume was 200 µl. After 3 min of preincubation at 37°C, the incubation reactions were initiated by the addition of NADPH (2.0 mM). After undergoing incubation for 60 min, the reactions were terminated with an equal This article has not been copyedited and formatted. The final version may differ from this version. each incubation was performed in duplicate. All incubation conditions for the isolated metabolites 2, 3, 4 and 5 were the same as described above for PPD.
Incubation of PPD with Human Hepatocytes. Stock solution of PPD was prepared in MeOH. The final concentration of MeOH in the incubation was 0.5% (v/v). All the incubations were conducted at 37°C for 3 h in Williams' E medium containing PPD (50 µM) and hepatocytes (2 million cells/ml).
Incubations in the presence of PPD at time 0 h or in the absence of PPD at 3 h served as negative controls. Reactions were quenched with an equal volumes of acetonitrile, each incubation was performed in duplicate. were carefully thawed on ice prior to the experiment. HLM proteins (1.0 mg/ml) were added to a solution of 10 mM MgCl 2 , 2 mM UDP-glucuronic acid (UDPGA) and 25 μ g/mL alamethicin in 50 mM Tris-HCl buffer (pH 7.4). The total incubation volume was 200 µl. After 3 min of preincubation at 37°C, the incubation reactions were initiated by the addition of PPD (50 µM). After undergoing incubation for 120 min, the reactions were terminated with an equal volume of ice-cold acetonitrile.
Microsomal Incubations of PPD
Incubations in the presence of PPD at time 0 min served as negative controls, each incubation was performed in duplicate. The incubation conditions for 2 and 3 were the same as described above for PPD. and 159. M6-1 and M6-2 were tentatively identified as 24,25-vicinal diol derivatives of PPD, which may be generated through the ring opening reaction of the 24,25-epoxides. Since M6-1 and M6-2 are 24-epimers, the stereochemistry at C-24 is matter to discuss. It was observed that the 24S-epimers 2, 4
Preparation of Samples for LC/MS
and M7-1 were more easily be eluted from the colum than the corresponding 24R-epimers 3, 5 and M7-2 under the experimental conditions. In light of this observation, bearing in mind that the epimers generated from the same parent structure usually had similar chromatographic behaviors, M6-1 and M6-2 were tentatively assigned as the 24S-and 24R-epimer, respectively.
Metabolite M7. Metabolites M7-1 and M7-2 were eluted at 16.0 and 16.9 min, respectively. Both showed a precursor ion at m/z 653, which was 192 Da larger than that of PPD. Their mass spectra were This article has not been copyedited and formatted. The final version may differ from this version. The remaining degree of unsaturation was, therefore, attributed to a ring in the side chain. In addition, one methine signal (δ C 87.42, d, C-24; δ H 3.88, dd, J = 10.8, 5.6 Hz, H-24) and an OH-bearing tertiary carbon atom (δ C 70.00, s, C-25) were observed, indicating the presence of the 20,24-epoxide moiety and a hydroxyl group at C-25. The assigned structure for 2 was confirmed by its 2D NMR spectra ( (Table 1 ) of 3 and 2 revealed main differences at the δ values of Me-21 and Me-26, in which the former was upfield shifted (-0.14 ppm), whereas the latter was downfield shifted (+ 0.17 ppm). Both shifts supported the inversion of the configuration at C-24. Furthermore, the α-orientation of H-24 was also supported by rotating frame nuclear Overhauser effect spectroscopy. The clear NOE cross-peak between H-24 and Me-21 suggest that both are orientated on the same face (α) of the molecule according to the drawn structure of 3 ( C NMR resonance of C-2 and C-4 to significantly shift downfield (+ 5.50 ppm and + 7.58 ppm). The assigned structure for 4 was further confirmed by its 2D NMR spectra (Fig. 6 ).
Compound 5 also had a molecular formula C 30 H 50 O 4 , which was established by HR-ESI-MS (m/z 497.3626 [M + Na] + , calc. 497.3607). Analysis of the 1 H and 13 C NMR spectra of 5 revealed a close relationship with both 3 and 4. In fact, 5 shares the same proton sequence and framework as 4, as well as possesses the same side chain as 3. Detailed analysis of its 2D NMR spectra allowed the unambiguous definition of the structure of 5 (Fig. 6 ).
This article has not been copyedited and formatted. The final version may differ from this version. (Fig. 7A) ; their retention times and mass spectral fragmentation patterns were identical to those of M1-1, 2, and 3, respectively, and the mass spectral response of 2 was stronger than those of 3. Compounds 2 and 3
were detected in the reaction solution of 60 min, and the mass spectral response of 2 and 3 were comparable (Fig. 7B ). This suggests that M1-1 might rearranged to form 3 with the prolongation of the reaction time.
Theoretically, oxidization of PPD with 3-chloroperoxybenzoic acid could resulted in the formation of 24,25-epoxides in an equivalent mixture of 24-epimers ( biotransformative pathway is important to the pharmacological activities of ginsenosides (Kasai et al., 2000) . In addition, the ginsenosides have been hypothesized to exert their pharmacological effects through their equally important metabolite, PPD (Hasegawa, 2004) . However, the details regarding the metabolic pathway of PPD after absorption from the digestive tract and the structures of the metabolites were unclear. This study has determined its metabolically labile sites and its metabolite profile in humans.
Since the animal experimentes shows that the peak concentration of PPD in rat liver was about 20 µM after an oral administration of 50 mg/kg. And in our preliminary experimentes, we found that the types of PPD metabolites detected in human liver microsomes changed unconspicuous in the concentration range of 10-50 µM. Because higher concentration of the metabolites make for the mass-spectrometric detection, we choose 50 µM as the final incubation concentration. Furthermore, similar PPD metabolites were found in both human liver microsomes and rat feces receiving PPD administration. Our previous 3 H radiolabelled experiment on this compound shows that about 74.2%
of the orally administered dose is excreted in the feces within 48 h. In order to obtain the reference substances of PPD metabolites, 20 rats were given continuous oral PPD administration for 11 days, and the rat feces samples were collected within a period of 0-288 h (48 h after the last dosing) for chemical examination.
Using liquid chromatography-electrospray ionization (ESI) ion trap mass spectrometry, 24
This article has not been copyedited and formatted. The final version may differ from this version. that the enzyme-mediated biotransformation of PPD metabolites having a substituted tetrahydrofuran ring, such as 2, 3, 4 and 5, might also be stereoselective. It seems that the 24S-epimers were more susceptible to further oxidative biotransformation than 24R-epimers in HLMs. From the results of this study, the metabolic pathways of PPD in humans have been postulated (Fig. 9) .
It is believed that, epoxides formed by bioactivation readily confer covalent binding to thiol group containing proteins by nucleophilic attack. The covalent binding and formation of drug-protein adducts are generally considered to be related to drug toxicity (Zhou et al., 2005) . To evaluate their reactivity, nucleophilic GSH (5 mM) was incorporated as an exogenous agent to trap 24,25-epoxide metabolites of PPD in incubations of NADPH-supplemented human liver microsomes. However, LC/MS analyses of the incubation mixture after 60 min indicated that there were no GSH conjugates observed. Neither GSH conjugates were detected in human hepatocyte incubations responsible for the 24,25-epoxide metabolites. It appears that the transformation of 24,25-epoxide metabolites of PPD to corresponding GSH conjugates may be very limited in humans.
Complete and reliable assignment of spectroscopic data is crucial for confirming chemical structures and evaluating purity of compounds. To the best of our knowledge, the 13 C NMR data of natural products 2 (Appendino et al., 1992) , 3 (Yosioka et al., 1972) , 4 (Appendino et al., 1992) , and 5 (Appendino et al., 1992; Valverde et al., 1985) have been completely assigned in previous works.
However, only their incomplete 1 H NMR assignments have been reported. In this study, a thorough spectroscopic analysis of compounds 2-5 has been undertaken. Herein, a complete assignment of the 1 H NMR data of compounds 2-5 is presented based on an extensive analysis of DEPT and 2D NMR spectra, including HSQC, 1 H-1 H COSY, HMBC, and NOESY (Tables 1 and 2 ). This article has not been copyedited and formatted. The final version may differ from this version. 
